Monitoring the rare diseases landscape

The UK's Rare Disease Research Landscape Steering Group, spanning government, industry, and charitable funders, needed to understand the current state of rare disease research across all funding sources to inform future policy decisions. The group used Clarivate's data and analytical capabilities to gain visibility into research activity regardless of who funded it. The page states this gave the group "detailed insights and data that allowed them to define their future direction" for rare disease research strategy and planning. No further numeric outcomes are given on the page.

Clarivate owns Cortellis, the curated competitive-intelligence and pipeline-tracking platform standard in pharma portfolio-management teams.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.